Thiophene-Based Optical Ligands That Selectively Detect Aβ Pathology in Alzheimer's Disease.

Chembiochem : a European Journal of Chemical Biology
Therése KlingstedtK Peter R Nilsson

Abstract

In several neurodegenerative diseases, the presence of aggregates of specific proteins in the brain is a significant pathological hallmark; thus, developing ligands able to bind to the aggregated proteins is essential for any effort related to imaging and therapeutics. Here we report the synthesis of thiophene-based ligands containing nitrogen heterocycles. The ligands selectively recognized amyloid-β (Aβ) aggregates in brain tissue from individuals diagnosed neuropathologically as having Alzheimer's disease (AD). The selectivity for Aβ was dependent on the position of nitrogen in the heterocyclic compounds, and the ability to bind Aβ was shown to be reduced when introducing anionic substituents on the thiophene backbone. Our findings provide the structural and functional basis for the development of ligands that can differentiate between aggregated proteinaceous species comprised of distinct proteins. These ligands might also be powerful tools for studying the pathogenesis of Aβ aggregation and for designing molecules for imaging of Aβ pathology.

References

Aug 1, 1988·Journal of Neurochemistry·F PrelliB Frangione
Jul 1, 1997·Neurobiology of Aging·H Braak, E Braak
Mar 11, 1999·Annals of Neurology·J L Price, J C Morris
Aug 15, 2000·Journal of Structural Biology·R A Crowther, M Goedert
Sep 5, 2002·Free Radical Biology & Medicine·Ulf T Brunk, Alexei Terman
Jun 13, 2003·Journal of Medicinal Chemistry·Chester A MathisWilliam E Klunk
Mar 3, 2004·Annals of Neurology·William E KlunkBengt Långström
May 19, 2004·The International Journal of Biochemistry & Cell Biology·Alexei Terman, Ulf T Brunk
Aug 17, 2004·The Journal of Organic Chemistry·Jon C AntillaStephen L Buchwald
Sep 23, 2006·Science·Melanie Meyer-LuehmannMathias Jucker
Nov 10, 2007·Science·John Collinge, Anthony R Clarke
Nov 21, 2007·Nature Methods·Christina J SigurdsonAdriano Aguzzi
Apr 3, 2009·Brain : a Journal of Neurology·Clifford R JackUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Aug 20, 2009·Acta Neuropathologica·Rebecca F RosenLary C Walker
Jan 20, 2010·Lancet Neurology·Clifford R JackJohn Q Trojanowski
May 27, 2010·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Dean F WongMichael J Pontecorvo
Sep 6, 2011·Journal of Alzheimer's Disease : JAD·Ali TaghaviBoris Schmidt
Feb 11, 2012·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Zsolt CselényiLars Farde
Jul 13, 2012·The New England Journal of Medicine·Randall J BatemanUNKNOWN Dominantly Inherited Alzheimer Network
Mar 26, 2013·ACS Chemical Biology·Sofie NyströmK Peter R Nilsson
Jul 2, 2014·Proceedings of the National Academy of Sciences of the United States of America·Jan StöhrStanley B Prusiner
Jul 2, 2014·Proceedings of the National Academy of Sciences of the United States of America·Joel C WattsStanley B Prusiner
Dec 17, 2014·Lancet Neurology·Victor L VillemagneChristopher C Rowe
Feb 18, 2015·Brain : a Journal of Neurology·Mark L CohenJiri G Safar
Aug 8, 2015·Science Translational Medicine·Uli S HerrmannAdriano Aguzzi
Sep 22, 2015·Chemistry : a European Journal·Hamid ShiraniK Peter R Nilsson
Apr 2, 2016·Scientific Reports·K RajasekharT Govindaraju
Nov 5, 2016·The Journal of Experimental Medicine·Jing L GuoVirginia M Y Lee
Dec 21, 2016·Annals of Neurology·Marta MarquiéTeresa Gómez-Isla
Apr 1, 2017·Alzheimer's Research & Therapy·Kok Pin NgPedro Rosa-Neto
Jun 27, 2017·Biosensors & Bioelectronics·K RajasekharThimmaiah Govindaraju
Jul 6, 2017·Nature·Anthony W P FitzpatrickSjors H W Scheres
Sep 20, 2017·Chemistry : a European Journal·Hamid ShiraniK Peter R Nilsson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.